I'm transfecting siRNA using lipofectamine RNAiMAX (at 7.5 uL / well in 6-well plate), into gastric cancer cells (500000 cells/well, in a 6 well plate), and using qRT-PCR assay to test the knockdown efficiency. At the 3rd day, there is no noticeable change in the cell morphology from the negative siRNA compared to the normal cells and significant change in the targeted-siRNA cells (I'm using 25 nM siRNA). But the PCR showed a significant downregulation of targeted gene in both negative siRNA and targeted-siRNA . Has anyone encountered this problem before? Can somebody please explain why this is happening?